Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience

ObjectiveTherapy for autoimmune hepatitis (AIH) consists of steroid induction therapy, followed by maintenance therapy with azathioprine. However, up to 20% of patients experience either insufficient response or intolerance on first-line therapy. Calcineurin inhibitors (CNIs) are frequently used whe